{"id":5771,"date":"2024-09-09T07:26:50","date_gmt":"2024-09-09T12:26:50","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5771"},"modified":"2025-06-27T08:38:43","modified_gmt":"2025-06-27T13:38:43","slug":"nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u30ea\u30b9\u30dc\u30f3\u3067\u958b\u50ac\u3055\u308c\u308b\u7db2\u819c\u5b66\u4f1a\u304a\u3088\u3073\u5148\u9032\u7642\u6cd5\u30e8\u30fc\u30ed\u30c3\u30d1\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u767a\u8868\u3092\u767a\u8868"},"content":{"rendered":"
\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a0<\/span>2024\u5e749\u67089\u65e5<\/span><\/span>\u00a0 \u2014 <\/span>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001\u00a0<\/span>\u7db2\u819c\u5b66\u4f1a57\u756a\u76ee<\/sup>\u00a0\u5e74\u6b21\u5b66\u8853\u4f1a\u8b70<\/a>\u00a0\u305d\u3057\u3066\u00a0<\/span>\u30a2\u30c9\u30d0\u30f3\u30b9\u30c8\u30fb\u30bb\u30e9\u30d4\u30fc\u30ba\u30fb\u30e8\u30fc\u30ed\u30c3\u30d1<\/a>\u00a02\u306e\u9593\u306b\u884c\u308f\u308c\u308b<\/span>nd<\/sup>\u00a09\u6708\u306e\u9031\u00a0<\/span>\u30ea\u30b9\u30dc\u30f3\u3001\u30dd\u30eb\u30c8\u30ac\u30eb<\/span>\u3002\u8b1b\u6f14\u5185\u5bb9\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
\n

\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308b\u4f4e\u7528\u91cf\u307e\u305f\u306f\u9ad8\u7528\u91cfMCO-010\u5909\u7570\u975e\u4f9d\u5b58\u578b\u5149\u907a\u4f1d\u5b66\u7684\u7642\u6cd5\u3092\u53d7\u3051\u305f\u60a3\u8005\u306eBCVA\u5206\u6790\uff1a\u30d5\u30a7\u30fc\u30ba1\u8a66\u9a13\u306e100\u9031\u9593\u306eTOPLINE\u7d50\u679c\u00a02b<\/span>\/3 \u30e9\u30f3\u30c0\u30e0\u5316\u507d\u85ac\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\uff08RESTORE\uff09
\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u907a\u4f1d\u6027\u75be\u60a3\u3001\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3001\u5909\u6027\u75be\u60a3<\/a>
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b>2024\u5e749\u670811\u65e5<\/span>
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>\u5348\u5f8c4\u664225\u5206<\/span>\u00a0\u897f
\u4f4d\u7f6e\uff1a\u00a0<\/b>\u30da\u30c9\u30ed \u30ec\u30a4\u30bf\u30aa \u30dc\u30fc\u30eb\u30eb\u30fc\u30e0\u3001\u30d5\u30a9\u30fc\u30b7\u30fc\u30ba\u30f3\u30ba \u30db\u30c6\u30eb \u30ea\u30c3\u30c4\u3001\u00a0\u30ea\u30b9\u30dc\u30f3<\/span>
\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b>\u30a2\u30ca\u30c8\u30fb\u30ed\u30fc\u30a6\u30a7\u30f3\u30b7\u30e5\u30bf\u30a4\u30f3<\/span>\u3001\u533b\u5b66\u535a\u58eb\u3001\u533b\u5b66\u535a\u58eb\u3001\u773c\u79d1\u90e8\u9580\u6559\u6388\u517c\u90e8\u9577\u3001\u00a0\u30c6\u30eb\u30a2\u30d3\u30d6\u5927\u5b66<\/span><\/p>\n

\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3067\u306f\u3001Loewenstein \u535a\u58eb\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u306b\u5bfe\u3059\u308b\u3001\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3 (MCO) \u7642\u6cd5\u306e\u7814\u7a76\u7d42\u4e86\u6642\u306e 100 \u9031\u9593\u306e RESTORE \u30c7\u30fc\u30bf\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n

\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u795e\u7d4c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u6c11\u4e3b\u5316
\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0 \u907a\u4f1d\u5b50\u6cbb\u7642\uff1a\u958b\u767a\u3068\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u306b\u6ce8\u76ee
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02024\u5e749\u670811\u65e5<\/span>
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:<\/b>\u00a0\u5348\u5f8c4\u664215\u5206\uff08\u897f\u6642\u9593\uff09
\u4f4d\u7f6e\uff1a<\/b>\u00a0\u30a8\u30b9\u30c8\u30ea\u30eb\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u3001\u00a0\u30ea\u30b9\u30dc\u30f3<\/span>
\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a<\/b>\u00a0\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/p>\n

\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u4e2d\u3067\u3001\u907a\u4f1d\u6027\u7db2\u819c\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u306e\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u5149\u907a\u4f1d\u5b66\u7684\u907a\u4f1d\u5b50\u6cbb\u7642\u3068\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u306e\u6cbb\u7642\u306e\u305f\u3081\u306e\u753b\u50cf\u8a98\u5c0e\u306b\u3088\u308b\u7a7a\u9593\u6a19\u7684\u30ec\u30fc\u30b6\u30fc\u907a\u4f1d\u5b50\u9001\u9054\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u95a2\u3059\u308b\u6700\u8fd1\u306e\u958b\u767a\u3068\u9032\u6b69\u3092\u5f37\u8abf\u3057\u307e\u3059\u3002\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u5f8c\u306f\u3001\u00a0\u5348\u5f8c4\u664245\u5206<\/span>\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u307e\u305f\u3001\u00a0\u201c<\/b>\u300c\u67d4\u8edf\u6027\u306e\u6d3b\u7528\uff1a\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u306e\u305f\u3081\u306e\u9069\u5fdc\u578b\u30d9\u30af\u30bf\u30fc\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u6d3b\u7528\u300d\u3068\u984c\u3057\u305f\u30bb\u30c3\u30b7\u30e7\u30f3\u304c\u30012024\u5e749\u670812\u65e5\u5348\u5f8c1\u664245\u5206\uff5e\u5348\u5f8c3\u6642\uff08\u7c73\u56fd\u897f\u90e8\u6642\u9593\uff09\u306b\u958b\u50ac\u3055\u308c\u307e\u3059\u3002.

<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u8981\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f (NCT04945772<\/a>\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08NCT05417126<\/a>\uff09\u3002 MCO-010 \u306f\u3001RP \u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u306e\u4e21\u65b9\u3067 FDA \u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u304a\u3088\u3073 FDA \u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u7406\u7684\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308b MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
(212) 600-1902
PR@nanostherapeutics.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0Sept. 9, 2024\u00a0 \u2014 Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced presentations at the\u00a0Retina Society 57th\u00a0Annual Scientific Meeting\u00a0and at\u00a0Advanced Therapies Europe\u00a0taking place during the 2nd\u00a0week of September in\u00a0Lisbon, Portugal. Details for the presentations are as follows: Title:\u00a0BCVA Analysis of Patients Treated with Low- or High-Dose MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 100-week TOPLINE Results from a Phase\u00a02b\/3 Randomized, Sham-Controlled Clinical Trial (RESTORE)Session Title:\u00a0Genetic Diseases, Dystrophies & DegenerationsSession Date:\u00a0September 11, 2024Session Time:\u00a04:25 p.m.\u00a0WESTLocation:\u00a0Pedro Leitao Ballroom, Four Seasons Hotel Ritz,\u00a0LisbonPresenter:\u00a0Anat Loewenstein, MD, MHA, Professor and Director, Division of Ophthalmol.,\u00a0Tel Aviv University In her presentation, Dr. Loewenstein will highlight the end-of-study 100 […]<\/p>\n","protected":false},"author":6,"featured_media":5772,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-09T12:26:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T13:38:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon\",\"datePublished\":\"2024-09-09T12:26:50+00:00\",\"dateModified\":\"2025-06-27T13:38:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/\",\"name\":\"Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg\",\"datePublished\":\"2024-09-09T12:26:50+00:00\",\"dateModified\":\"2025-06-27T13:38:43+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/09\\\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30ea\u30b9\u30dc\u30f3\u3067\u958b\u50ac\u3055\u308c\u308b\u7db2\u819c\u5b66\u4f1a\u304a\u3088\u3073\u5148\u9032\u6cbb\u7642\u30e8\u30fc\u30ed\u30c3\u30d1\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-09-09T12:26:50+00:00","article_modified_time":"2025-06-27T13:38:43+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon","datePublished":"2024-09-09T12:26:50+00:00","dateModified":"2025-06-27T13:38:43+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/"},"wordCount":382,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/","url":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30ea\u30b9\u30dc\u30f3\u3067\u958b\u50ac\u3055\u308c\u308b\u7db2\u819c\u5b66\u4f1a\u304a\u3088\u3073\u5148\u9032\u6cbb\u7642\u30e8\u30fc\u30ed\u30c3\u30d1\u5e74\u6b21\u7dcf\u4f1a\u3067\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg","datePublished":"2024-09-09T12:26:50+00:00","dateModified":"2025-06-27T13:38:43+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_LI_RetinaSociety24_Loewenstein_V1.jpg","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/09\/nanoscope-therapeutics-announces-presentations-at-the-retina-society-and-advanced-therapies-europe-annual-meetings-in-lisbon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Announces Presentations at the Retina Society and Advanced Therapies Europe Annual Meetings in Lisbon"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5771"}],"version-history":[{"count":3,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5771\/revisions"}],"predecessor-version":[{"id":9020,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5771\/revisions\/9020"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5772"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}